 | Up a level |
Journal Article
Bloos, Frank 
ORCID: 0000-0002-0767-7941, Held, Juergen, Kluge, Stefan ORCID: 0000-0001-8391-3988, Simon, Philipp, Kogelmann, Klaus, de Heer, Geraldine, Kuhn, Sven-Olaf, Jarczak, Dominik ORCID: 0000-0003-0480-2089, Motsch, Johann, Hempel, Gunther, Weiler, Norbert, Weyland, Andreas, Druener, Matthias, Gruendling, Matthias, Meybohm, Patrick, Richter, Daniel, Jaschinski, Ulrich, Moerer, Onnen, Guenther, Ulf, Schaedler, Dirk, Weiss, Raphael, Putensen, Christian, Castellanos, Ixchel, Kurzai, Oliver, Schlattmann, Peter, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Bauer, Michael and Thomas-Rueddel, Daniel
(2022).
(1 -> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Intensive Care Med., 48 (7).
S. 865 - 876.
NEW YORK:
SPRINGER.
ISSN 1432-1238
Westermann, Isabella, Gastine, Silke ORCID: 0000-0002-1069-6123, Mueller, Carsten, Rudolph, Wiebke, Peters, Frank, Bloos, Frank ORCID: 0000-0002-0767-7941, Pletz, Mathias and Hagel, Stefan ORCID: 0000-0003-2999-6131
(2021).
Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis.
Br. J. Clin. Pharmacol., 87 (11).
S. 4293 - 4304.
HOBOKEN:
WILEY.
ISSN 1365-2125
Bloos, Frank ORCID: 0000-0002-0767-7941, Held, Juergen, Schlattmann, Peter, Brillinger, Nicole, Kurzai, Oliver, Cornely, Oliver A. and Thomas-Rueddel, Daniel
(2018).
(1,3)-beta-D-glucan-based diagnosis of invasive Candida infection versus culturebased diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Trials, 19.
LONDON:
BMC.
ISSN 1745-6215